Research Studies Patient Care Medical Treatments Mental Health Epidemiology Public Health Chronic Conditions Clinical Research Medical Research Clinical Trials
Real-world evidence from WashU Medicine shows that lecanemab is safe for early-stage Alzheimer's patients under specialized care, with severe adverse events affecting only 1% of treated individuals.